Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 19:58
Regeneron Pharmaceuticals Price : 828.72 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 835.74 | 847.00 | 826.64 | 834.04 | 786921.0 |
| Aug 20, 2026 | 831.70 | 840.82 | 826.05 | 826.64 | 596475.0 |
| Aug 19, 2026 | 817.17 | 844.92 | 815.38 | 840.84 | 750446.0 |
| Aug 18, 2026 | 814.00 | 821.02 | 805.93 | 810.24 | 779073.0 |
| Aug 17, 2026 | 801.76 | 813.18 | 795.73 | 805.93 | 541306.0 |
| Aug 14, 2026 | 802.35 | 806.54 | 792.57 | 803.48 | 425600.0 |
| Aug 13, 2026 | 802.21 | 815.80 | 794.49 | 805.97 | 709747.0 |
| Aug 12, 2026 | 790.55 | 801.36 | 784.61 | 797.99 | 575164.0 |
| Aug 11, 2026 | 808.80 | 813.63 | 796.66 | 797.00 | 939190.0 |
| Aug 10, 2026 | 781.72 | 809.09 | 775.83 | 808.05 | 1.214M |
| Aug 07, 2026 | 774.47 | 785.99 | 767.17 | 784.36 | 837598.0 |
| Aug 06, 2026 | 777.85 | 780.95 | 762.78 | 772.11 | 783951.0 |
| Aug 05, 2026 | 767.98 | 782.59 | 763.31 | 768.58 | 532483.0 |
| Aug 04, 2026 | 753.76 | 763.54 | 747.00 | 760.66 | 817280.0 |
| Aug 03, 2026 | 769.54 | 772.75 | 756.44 | 759.24 | 842730.0 |
| Jul 31, 2026 | 726.69 | 764.75 | 724.79 | 762.63 | 1.159M |
| Jul 30, 2026 | 701.90 | 740.00 | 694.98 | 738.34 | 1.461M |
| Jul 29, 2026 | 699.38 | 702.60 | 691.00 | 695.42 | 1.022M |
| Jul 28, 2026 | 676.93 | 696.74 | 676.46 | 695.18 | 900408.0 |
| Jul 27, 2026 | 661.77 | 678.12 | 659.53 | 667.17 | 650985.0 |
| Jul 24, 2026 | 658.31 | 667.50 | 654.05 | 656.01 | 708393.0 |
| Jul 23, 2026 | 646.48 | 655.20 | 637.80 | 651.91 | 1.129M |
| Jul 22, 2026 | 676.43 | 676.80 | 648.90 | 651.18 | 872170.0 |
| Jul 21, 2026 | 672.55 | 678.67 | 666.87 | 675.19 | 529783.0 |
| Jul 20, 2026 | 674.72 | 681.74 | 669.88 | 672.15 | 624791.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.06 |
| Gilead Sciences, Inc. | 146.76 |
| AbbVie, Inc. | 264.49 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Amgen, Inc. | 443.84 |
Price Related Metrics
| PE Ratio | 20.48 |
| PS Ratio | 5.713 |
| PEG Ratio | 10.48 |
| Price to Book Value | 2.702 |
| Price to Free Cash Flow | 24.83 |
| Earnings Yield | 4.88% |
| Market Cap | 85.69B |
| PEGY Ratio | 8.543 |
| Operating PE Ratio | 21.26 |
| Normalized PE Ratio | 19.32 |